Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Research at Kowa leads to potent inhibitors of IgE antibody production

May 21, 1998

Heterocyclic cholesterol biosynthesis inhibitors discovered at Zeneca

May 21, 1998

Merck KGaA synthesizes new series of PDE IV inhibitors

May 21, 1998

Boehringer Ingelheim prepares novel immunomodulators

May 21, 1998

DuPont Merck presents new anticoagulants

May 21, 1998

Celgene claims agents for reducing cytokine levels

May 20, 1998

Selective thrombin inhibitors described by Merck scientists

May 20, 1998

New treatments for Alzheimer's disease in the pipeline at Schering-Plough

May 20, 1998

Chiroscience prepares new peptidyl inhibitors of MMPs and TNF production

May 20, 1998

New PDE IV inhibitors from Euroceltique

May 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...